Status:
COMPLETED
Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
45-70 years
Phase:
NA
Brief Summary
Atrial fibrillation is the most common arrhythmia post coronary bypass surgery, currently B-blockers are the class I indication to prevent AF post CABG. We decide to evaluate use of propranolol and am...
Detailed Description
In this double blind randomized study 240 consecutive patients underwent elective coronary artery bypass grafting, being randomized prospectively into three groups, propranolol (p) (n=80), amiodarone ...
Eligibility Criteria
Inclusion
- Patient who are going to have elective CABG
- Signing informed consent
Exclusion
- EF\<35%
- Bradycardia\<60 per min
- Hypotension\< 100 mmhg
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00654290
Start Date
March 1 2007
End Date
February 1 2008
Last Update
April 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shiraz University of Medical Sciences/Cardiac Surgery and Cardiology Ward/Namazi and Shahid Faghihi Hospital
Shiraz, Fars, Iran, 71345